EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Complement pathway dysregulation and astrocyte alterations in Down syndrome: evidence from postmortem brain tissue and iPSC-derived astrocytes

André Luíz Teles E Silva, Pedro Henrique Prado de Oliveira iD, Bruno Yukio Yokota-Moreno, Jéssica da Silva Fausto, Jonatan Peña Avila, Helder I Nakaya, Andréa Laurato Sertié, Bruna Lancia Zampieri

Acta Neuropathologica Communications · 2025

DOI: 10.1186/s40478-025-02090-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica Communications, 2025. Verfasst von André Luíz Teles E Silva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Astrocytes, Down Syndrome, Induced Pluripotent Stem Cells, Complement System Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Down syndrome (DS), or trisomy 21 (T21), resulting from an extra copy of chromosome 21, occurs in 1 in 700-1,000 live births. Neuroinflammation is increasingly recognized as a critical contributor to DS neuropathology, although its underlying drivers remain unclear. METHODS: In this study, we analyzed available single-nucleus RNA sequencing (snRNAseq) data from postmortem cortical brains of individuals with DS and controls aged 36 years or younger, focusing specifically on astrocyte-enriched clusters. This analysis revealed significant alterations in complement system gene sets. To further investigate these findings, we employed a human in vitro model using astrocytes differentiated from urine-derived induced pluripotent stem cells (iPSCs) obtained from individuals with DS (T21-iPSCs). To our knowledge, this is the first study to evaluate both gene expression and protein levels of secreted complement components in T21-iPSC-derived astrocytes. RESULTS: snRNAseq re-analyzes identified an upregulation of complement system components, including C1R, C1S, C2, C4A, C4B, C5, C5AR1, C6, C8, CD59, CFI, and FCN2, and of glutamate transporters SLC1A3 (EAAT1/GLAST-1) and SLC1A2 (EAAT2/GLT-1) in DS astrocytes. Results from the in vitro model revealed distinct phenotypic changes in T21-iPSC-derived astrocytes, including enlarged cell and nuclear sizes, and enhanced glutamate uptake. Elevated levels of C5aR1 and MASP1 transcripts, as well as increased C4 protein secretion in culture supernatants, suggest dysregulation of the complement system in DS. CONCLUSIONS: These findings highlight the potential contribution of astrocyte-driven complement signaling to DS neuropathogenesis. While further validation is needed, this work points to a candidate pathway that may serve as a target for future therapeutic investigation to improve the quality of life for individuals with DS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesDown SyndromeInduced Pluripotent Stem CellsComplement System ProteinsBrainHumansAdultFemaleMaleAutopsyCells, CulturedYoung Adult

Stichwörter der Autor:innen

AstrocytesComplement systemDown syndromeInduced pluripotent stem cellsTrisomy 21

Substanzen

Complement System Proteins

Autor:innen und Institutionen

  • Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Institute of Technology and Leadership, São Paulo, Brazil.
  • School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
  • Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. brunazampieri@gmail.com.

ORCID-Profile: Pedro Henrique Prado de Oliveira

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Teles E Silva, A. L., Prado de Oliveira, P. H., Yokota-Moreno, B. Y., da Silva Fausto, J., Avila, J. P., Nakaya, H. I., Sertié, A. L., & Zampieri, B. L. (2025). Complement pathway dysregulation and astrocyte alterations in Down syndrome: evidence from postmortem brain tissue and iPSC-derived astrocytes. Acta Neuropathologica Communications. https://doi.org/10.1186/s40478-025-02090-0

Vancouver

Teles E Silva AL, Prado de Oliveira PH, Yokota-Moreno BY, da Silva Fausto J, Avila JP, Nakaya HI, et al. Complement pathway dysregulation and astrocyte alterations in Down syndrome: evidence from postmortem brain tissue and iPSC-derived astrocytes. Acta Neuropathologica Communications. 2025. doi:10.1186/s40478-025-02090-0

BibTeX
@article{TelesESilva2025,
  author = {Teles E Silva, André Luíz and Prado de Oliveira, Pedro Henrique and Yokota-Moreno, Bruno Yukio and da Silva Fausto, Jéssica and Avila, Jonatan Peña and Nakaya, Helder I and Sertié, Andréa Laurato and Zampieri, Bruna Lancia},
  title = {Complement pathway dysregulation and astrocyte alterations in Down syndrome: evidence from postmortem brain tissue and iPSC-derived astrocytes},
  journal = {Acta Neuropathologica Communications},
  year = {2025},
  doi = {10.1186/s40478-025-02090-0}
}
Kostenlos starten →